▶ 調査レポート

高度ドラッグデリバリーシステムの世界市場(~2026年)

• 英文タイトル:Global Advanced Drug Delivery Systems Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。高度ドラッグデリバリーシステムの世界市場(~2026年) / Global Advanced Drug Delivery Systems Market Size, Status and Forecast 2020-2026 / MRC2-11QY13587資料のイメージです。• レポートコード:MRC2-11QY13587
• 出版社/出版日:QYResearch / 2020年11月30日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、92ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は高度ドラッグデリバリーシステムのグローバル市場について調査・分析したレポートです。種類別(経口ドラッグデリバリー、肺ドラッグデリバリー、経皮ドラッグデリバリー、非経口ドラッグデリバリー)市場規模、用途別(病院、専門クリニック、臨床研究開発センター)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別高度ドラッグデリバリーシステムの競争状況、市場シェア
・世界の高度ドラッグデリバリーシステム市場:種類別市場規模 2015年-2020年(経口ドラッグデリバリー、肺ドラッグデリバリー、経皮ドラッグデリバリー、非経口ドラッグデリバリー)
・世界の高度ドラッグデリバリーシステム市場:種類別市場規模予測 2021年-2026年(経口ドラッグデリバリー、肺ドラッグデリバリー、経皮ドラッグデリバリー、非経口ドラッグデリバリー)
・世界の高度ドラッグデリバリーシステム市場:用途別市場規模 2015年-2020年(病院、専門クリニック、臨床研究開発センター)
・世界の高度ドラッグデリバリーシステム市場:用途別市場規模予測 2021年-2026年(病院、専門クリニック、臨床研究開発センター)
・北米の高度ドラッグデリバリーシステム市場分析:米国、カナダ
・ヨーロッパの高度ドラッグデリバリーシステム市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの高度ドラッグデリバリーシステム市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の高度ドラッグデリバリーシステム市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの高度ドラッグデリバリーシステム市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):NeXstar Pharmaceuticals、West Pharmaceutical Services、AstraZeneca、Sequus Pharmaceuticals、3M、Novartis International
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted delivery for onsite drug release and absorption are the basis for the development of advanced drug delivery systems. Furthermore, the development of improved methods of drug delivery is preferred these days over the search for novel molecules. There are various dosage forms available by which a drug substance can be incorporated for efficacious delivery. Advancements in biotechnology and nanotechnology have significantly boosted the development of novel drug delivery approaches. Various interdisciplinary studies in the field of polymer science, pharmaceuticals, organic chemistry and molecular biology are required for the development of advanced drug delivery systems. The drug delivery system comprise of drug formulation, dosage form and mechanism of release. These advanced delivery systems have the potential of overcoming one of the major problem faced by the pharmaceutical industry for the onsite drug efficacy. Development of advanced drug delivery systems needs into consideration several factors such as pharmacodynamics, drug toxicity, immunogenicity, bio compatibility, pharmacokinetics as well as drug efficacy.
Various advantages of advanced drug delivery systems over the conventional delivery systems such as on site action, reduce dosing amount, increased drug efficacy, therapeutic success rate etc. support its market growth. In addition, increasing clinical research activities in the development of more advanced drug delivery systems would also be fuelling the market growth. Certain technical limitations in the development of methods, stringent regulations, high pricing for the advanced products, non-availability in the low income countries are some of the factors limiting the market growth of global advanced drug delivery systems.

Market Analysis and Insights: Global Advanced Drug Delivery Systems Market
The global Advanced Drug Delivery Systems market size is projected to reach US$ 184050 million by 2026, from US$ 178680 million in 2020, at a CAGR of 2.8%% during 2021-2026.

Global Advanced Drug Delivery Systems Scope and Market Size
Advanced Drug Delivery Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Advanced Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
NeXstar Pharmaceuticals
West Pharmaceutical Services
AstraZeneca
Sequus Pharmaceuticals
3M
Novartis International

Market segment by Type, the product can be split into
Oral Drug Delivery
Pulmonary Drug Delivery
Transdermal Drug Delivery
Parenteral Drug Delivery
Market segment by Application, split into
Hospitals
Specialized Clinics
Clinical Research & Development Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Advanced Drug Delivery Systems Revenue
1.4 Market by Type
1.4.1 Global Advanced Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral Drug Delivery
1.4.3 Pulmonary Drug Delivery
1.4.4 Transdermal Drug Delivery
1.4.5 Parenteral Drug Delivery
1.5 Market by Application
1.5.1 Global Advanced Drug Delivery Systems Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialized Clinics
1.5.4 Clinical Research & Development Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Advanced Drug Delivery Systems Market Perspective (2015-2026)
2.2 Global Advanced Drug Delivery Systems Growth Trends by Regions
2.2.1 Advanced Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Advanced Drug Delivery Systems Historic Market Share by Regions (2015-2020)
2.2.3 Advanced Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Advanced Drug Delivery Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Advanced Drug Delivery Systems Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Advanced Drug Delivery Systems Players by Market Size
3.1.1 Global Top Advanced Drug Delivery Systems Players by Revenue (2015-2020)
3.1.2 Global Advanced Drug Delivery Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Advanced Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Advanced Drug Delivery Systems Market Concentration Ratio
3.2.1 Global Advanced Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Advanced Drug Delivery Systems Revenue in 2019
3.3 Advanced Drug Delivery Systems Key Players Head office and Area Served
3.4 Key Players Advanced Drug Delivery Systems Product Solution and Service
3.5 Date of Enter into Advanced Drug Delivery Systems Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Advanced Drug Delivery Systems Historic Market Size by Type (2015-2020)
4.2 Global Advanced Drug Delivery Systems Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Advanced Drug Delivery Systems Market Size by Application (2015-2020)
5.2 Global Advanced Drug Delivery Systems Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Advanced Drug Delivery Systems Market Size (2015-2020)
6.2 Advanced Drug Delivery Systems Key Players in North America (2019-2020)
6.3 North America Advanced Drug Delivery Systems Market Size by Type (2015-2020)
6.4 North America Advanced Drug Delivery Systems Market Size by Application (2015-2020)

7 Europe
7.1 Europe Advanced Drug Delivery Systems Market Size (2015-2020)
7.2 Advanced Drug Delivery Systems Key Players in Europe (2019-2020)
7.3 Europe Advanced Drug Delivery Systems Market Size by Type (2015-2020)
7.4 Europe Advanced Drug Delivery Systems Market Size by Application (2015-2020)

8 China
8.1 China Advanced Drug Delivery Systems Market Size (2015-2020)
8.2 Advanced Drug Delivery Systems Key Players in China (2019-2020)
8.3 China Advanced Drug Delivery Systems Market Size by Type (2015-2020)
8.4 China Advanced Drug Delivery Systems Market Size by Application (2015-2020)

9 Japan
9.1 Japan Advanced Drug Delivery Systems Market Size (2015-2020)
9.2 Advanced Drug Delivery Systems Key Players in Japan (2019-2020)
9.3 Japan Advanced Drug Delivery Systems Market Size by Type (2015-2020)
9.4 Japan Advanced Drug Delivery Systems Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Advanced Drug Delivery Systems Market Size (2015-2020)
10.2 Advanced Drug Delivery Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Advanced Drug Delivery Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Advanced Drug Delivery Systems Market Size by Application (2015-2020)

11 India
11.1 India Advanced Drug Delivery Systems Market Size (2015-2020)
11.2 Advanced Drug Delivery Systems Key Players in India (2019-2020)
11.3 India Advanced Drug Delivery Systems Market Size by Type (2015-2020)
11.4 India Advanced Drug Delivery Systems Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Advanced Drug Delivery Systems Market Size (2015-2020)
12.2 Advanced Drug Delivery Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Advanced Drug Delivery Systems Market Size by Type (2015-2020)
12.4 Central & South America Advanced Drug Delivery Systems Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 NeXstar Pharmaceuticals
13.1.1 NeXstar Pharmaceuticals Company Details
13.1.2 NeXstar Pharmaceuticals Business Overview
13.1.3 NeXstar Pharmaceuticals Advanced Drug Delivery Systems Introduction
13.1.4 NeXstar Pharmaceuticals Revenue in Advanced Drug Delivery Systems Business (2015-2020))
13.1.5 NeXstar Pharmaceuticals Recent Development
13.2 West Pharmaceutical Services
13.2.1 West Pharmaceutical Services Company Details
13.2.2 West Pharmaceutical Services Business Overview
13.2.3 West Pharmaceutical Services Advanced Drug Delivery Systems Introduction
13.2.4 West Pharmaceutical Services Revenue in Advanced Drug Delivery Systems Business (2015-2020)
13.2.5 West Pharmaceutical Services Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Advanced Drug Delivery Systems Introduction
13.3.4 AstraZeneca Revenue in Advanced Drug Delivery Systems Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Sequus Pharmaceuticals
13.4.1 Sequus Pharmaceuticals Company Details
13.4.2 Sequus Pharmaceuticals Business Overview
13.4.3 Sequus Pharmaceuticals Advanced Drug Delivery Systems Introduction
13.4.4 Sequus Pharmaceuticals Revenue in Advanced Drug Delivery Systems Business (2015-2020)
13.4.5 Sequus Pharmaceuticals Recent Development
13.5 3M
13.5.1 3M Company Details
13.5.2 3M Business Overview
13.5.3 3M Advanced Drug Delivery Systems Introduction
13.5.4 3M Revenue in Advanced Drug Delivery Systems Business (2015-2020)
13.5.5 3M Recent Development
13.6 Novartis International
13.6.1 Novartis International Company Details
13.6.2 Novartis International Business Overview
13.6.3 Novartis International Advanced Drug Delivery Systems Introduction
13.6.4 Novartis International Revenue in Advanced Drug Delivery Systems Business (2015-2020)
13.6.5 Novartis International Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Advanced Drug Delivery Systems Key Market Segments
Table 2. Key Players Covered: Ranking by Advanced Drug Delivery Systems Revenue
Table 3. Ranking of Global Top Advanced Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Advanced Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Drug Delivery
Table 6. Key Players of Pulmonary Drug Delivery
Table 7. Key Players of Transdermal Drug Delivery
Table 8. Key Players of Parenteral Drug Delivery
Table 9. Global Advanced Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Advanced Drug Delivery Systems Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Advanced Drug Delivery Systems Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Advanced Drug Delivery Systems Market Share by Regions (2015-2020)
Table 13. Global Advanced Drug Delivery Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Advanced Drug Delivery Systems Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Advanced Drug Delivery Systems Market Growth Strategy
Table 19. Main Points Interviewed from Key Advanced Drug Delivery Systems Players
Table 20. Global Advanced Drug Delivery Systems Revenue by Players (2015-2020) (Million US$)
Table 21. Global Advanced Drug Delivery Systems Market Share by Players (2015-2020)
Table 22. Global Top Advanced Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Advanced Drug Delivery Systems as of 2019)
Table 23. Global Advanced Drug Delivery Systems by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Advanced Drug Delivery Systems Product Solution and Service
Table 26. Date of Enter into Advanced Drug Delivery Systems Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Advanced Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 29. Global Advanced Drug Delivery Systems Market Size Share by Type (2015-2020)
Table 30. Global Advanced Drug Delivery Systems Revenue Market Share by Type (2021-2026)
Table 31. Global Advanced Drug Delivery Systems Market Size Share by Application (2015-2020)
Table 32. Global Advanced Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 33. Global Advanced Drug Delivery Systems Market Size Share by Application (2021-2026)
Table 34. North America Key Players Advanced Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Advanced Drug Delivery Systems Market Share (2019-2020)
Table 36. North America Advanced Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 37. North America Advanced Drug Delivery Systems Market Share by Type (2015-2020)
Table 38. North America Advanced Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 39. North America Advanced Drug Delivery Systems Market Share by Application (2015-2020)
Table 40. Europe Key Players Advanced Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Advanced Drug Delivery Systems Market Share (2019-2020)
Table 42. Europe Advanced Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Advanced Drug Delivery Systems Market Share by Type (2015-2020)
Table 44. Europe Advanced Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Advanced Drug Delivery Systems Market Share by Application (2015-2020)
Table 46. China Key Players Advanced Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 47. China Key Players Advanced Drug Delivery Systems Market Share (2019-2020)
Table 48. China Advanced Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 49. China Advanced Drug Delivery Systems Market Share by Type (2015-2020)
Table 50. China Advanced Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 51. China Advanced Drug Delivery Systems Market Share by Application (2015-2020)
Table 52. Japan Key Players Advanced Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Advanced Drug Delivery Systems Market Share (2019-2020)
Table 54. Japan Advanced Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Advanced Drug Delivery Systems Market Share by Type (2015-2020)
Table 56. Japan Advanced Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Advanced Drug Delivery Systems Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Advanced Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Advanced Drug Delivery Systems Market Share (2019-2020)
Table 60. Southeast Asia Advanced Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Advanced Drug Delivery Systems Market Share by Type (2015-2020)
Table 62. Southeast Asia Advanced Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Advanced Drug Delivery Systems Market Share by Application (2015-2020)
Table 64. India Key Players Advanced Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 65. India Key Players Advanced Drug Delivery Systems Market Share (2019-2020)
Table 66. India Advanced Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 67. India Advanced Drug Delivery Systems Market Share by Type (2015-2020)
Table 68. India Advanced Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 69. India Advanced Drug Delivery Systems Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Advanced Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Advanced Drug Delivery Systems Market Share (2019-2020)
Table 72. Central & South America Advanced Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Advanced Drug Delivery Systems Market Share by Type (2015-2020)
Table 74. Central & South America Advanced Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Advanced Drug Delivery Systems Market Share by Application (2015-2020)
Table 76. NeXstar Pharmaceuticals Company Details
Table 77. NeXstar Pharmaceuticals Business Overview
Table 78. NeXstar Pharmaceuticals Product
Table 79. NeXstar Pharmaceuticals Revenue in Advanced Drug Delivery Systems Business (2015-2020) (Million US$)
Table 80. NeXstar Pharmaceuticals Recent Development
Table 81. West Pharmaceutical Services Company Details
Table 82. West Pharmaceutical Services Business Overview
Table 83. West Pharmaceutical Services Product
Table 84. West Pharmaceutical Services Revenue in Advanced Drug Delivery Systems Business (2015-2020) (Million US$)
Table 85. West Pharmaceutical Services Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Product
Table 89. AstraZeneca Revenue in Advanced Drug Delivery Systems Business (2015-2020) (Million US$)
Table 90. AstraZeneca Recent Development
Table 91. Sequus Pharmaceuticals Company Details
Table 92. Sequus Pharmaceuticals Business Overview
Table 93. Sequus Pharmaceuticals Product
Table 94. Sequus Pharmaceuticals Revenue in Advanced Drug Delivery Systems Business (2015-2020) (Million US$)
Table 95. Sequus Pharmaceuticals Recent Development
Table 96. 3M Company Details
Table 97. 3M Business Overview
Table 98. 3M Product
Table 99. 3M Revenue in Advanced Drug Delivery Systems Business (2015-2020) (Million US$)
Table 100. 3M Recent Development
Table 101. Novartis International Company Details
Table 102. Novartis International Business Overview
Table 103. Novartis International Product
Table 104. Novartis International Revenue in Advanced Drug Delivery Systems Business (2015-2020) (Million US$)
Table 105. Novartis International Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Advanced Drug Delivery Systems Market Share by Type: 2020 VS 2026
Figure 2. Oral Drug Delivery Features
Figure 3. Pulmonary Drug Delivery Features
Figure 4. Transdermal Drug Delivery Features
Figure 5. Parenteral Drug Delivery Features
Figure 6. Global Advanced Drug Delivery Systems Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Specialized Clinics Case Studies
Figure 9. Clinical Research & Development Centers Case Studies
Figure 10. Advanced Drug Delivery Systems Report Years Considered
Figure 11. Global Advanced Drug Delivery Systems Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Advanced Drug Delivery Systems Market Share by Regions: 2020 VS 2026
Figure 13. Global Advanced Drug Delivery Systems Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Advanced Drug Delivery Systems Market Share by Players in 2019
Figure 16. Global Top Advanced Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Advanced Drug Delivery Systems as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Advanced Drug Delivery Systems Revenue in 2019
Figure 18. North America Advanced Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Advanced Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Advanced Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Advanced Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Advanced Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Advanced Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Advanced Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed